Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo (Q44438000)

3 December 2017

Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo (English)

1 reference

3 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1383-5718(03)00049-4

1 January 2024

author name string

Nilüfer Aydemir

series ordinal

1

1 reference

3 December 2017

Rahmi Bilaloğlu

series ordinal

2

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

3 December 2017

9 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12742506

full work available at URL

1 January 2024

https://api.elsevier.com/content/article/PII:S1383571803000494?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1383-5718(03)00049-4

https://api.elsevier.com/content/article/PII:S1383571803000494?httpAccept=text/plain

1 January 2024

1 reference

https://api.crossref.org/works/10.1016/S1383-5718(03)00049-4

1 January 2024

1 reference

3 December 2017

537

1 reference

3 December 2017

1

1 reference

3 December 2017

43-51

1 reference

Characterisation of genotoxic properties of 2',2'-difluorodeoxycytidine.

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Combination therapy with gemcitabine in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Supraadditive effect of 2',2'-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Gemcitabine: a pharmacologic and clinical overview

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Interaction effects of 5-azacytidine with topoisomerase II inhibitors on CHO cells, as detected by cytogenetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Comparison of camptothecin derivatives presently in clinical trials: genotoxic potency and mitotic recombination

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Mammalian in vivo cytogenetic assays. Analysis of chromosome aberrations in bone marrow cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

The Clastogenic effect of Pyrimethamine (Daraprim) on human chromosomes in lymphocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Current cytogenetic methods for detecting exposure and effects of mutagens and carcinogens

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Cytogenetic effects of inhibition of topoisomerase I or II activities in the CHO mutant EM9 and its parental line AA8

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Induction of somatic mutation and recombination by four inhibitors of eukaryotic topoisomerases assayed in the wing spot test of Drosophila melanogaster.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Efficient induction of chromosome-type aberrations by topoisomerase II inhibitors closely associated with stabilization of the cleavable complex in cultured fibroblastic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Measurement and analysis of the chemotherapy-induced genetic instability in pediatric cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900049-4

7 January 2021

Induction of apoptosis by gemcitabine

series ordinal

6

1 reference

https://api.crossref.org/works/10.1016/S1383-5718(03)00049-4

1 January 2024

Identifiers

1 reference

3 December 2017

1 reference